Kwality Pharmaceuticals Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 — transcript filed; not yet summarisedQ4 FY26
Q4 FY26 earnings call
Kwality Pharmaceuticals reported Q4 FY26 revenue of Rs157.1 crore, up 35.8% year-on-year, and full-year FY26 revenue of Rs503 crore, up nearly 36% from Rs370 crore in FY25. EBITDA margins expanded from 22% to 24% and profit after tax grew 69% to Rs67 crore, with management citing improved cash conversion cycle and recovery of delayed Middle East receivables. Management reiterated FY27 targets of Rs650-700 crore revenue and Rs100 crore PAT, alongside a longer-term aspiration of Rs1,000 crore revenue by FY29.